Evidence map›Paper›PMID 37831395›Full record

ArticleStem cell reviews and reports2024

The Protective Effect of Chronic Intermittent Hypobaric Hypoxia on Preventing the Destruction of CD34

Hui Guo, Yilin Zhao, Rui Mu, Guangdao Zhang, Shuxian Chen, Xinwei Cao, Kangcan Liu, Yiran Liu, Baiyun Dai, Yuan Zhou and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Stem cell reviews and reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.9field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Hui Guo *Key Laboratory of Aging and Cancer Biology of Zhejiang Province, Hangzhou, China.
Yilin Zhao *Key Laboratory of Aging and Cancer Biology of Zhejiang Province, Hangzhou, China.
Rui MuCollege of Basic Medicine, Hebei Medical University, Shijiazhuang, China.
Guangdao ZhangDepartment of Prosthodontics, School of Stomatology, China Medical University, Shenyang, China.
Shuxian ChenCollege of Basic Medicine, Hebei Medical University, Shijiazhuang, China.
Xinwei CaoCollege of Basic Medicine, Hebei Medical University, Shijiazhuang, China.
Kangcan LiuCollege of Basic Medicine, Hebei Medical University, Shijiazhuang, China.
Yiran LiuCollege of Basic Medicine, Hebei Medical University, Shijiazhuang, China.
Baiyun DaiKey Laboratory of Aging and Cancer Biology of Zhejiang Province, Hangzhou, China.
Yuan ZhouState Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China. yuanzhou@ihcams.ac.cn.
Chuan WangDepartment of Pharmacology, Hebei Medical University, Shijiazhuang, China. wchpha@hotmail.com.
Jing YangKey Laboratory of Aging and Cancer Biology of Zhejiang Province, Hangzhou, China. yjphy@126.com.ORCID 0000-0002-3386-2964
Hebei Medical University · CNHangzhou Normal University · CNChina Medical University · CNChinese Academy of Medical Sciences & Peking Union Medical College · CNChinese Academy of Sciences · CN

Funding

National Natural Science Foundation of China 81900249Natural Science Foundation of Liaoning Province 2022-MS-230Natural Science Foundation of Zhejiang Province LY23H020001Steel and Iron Foundation of Hebei Province H2020206003
6 · The paper itself

Abstract

Aplastic anaemia (AA) is a haematopoietic disorder caused by immune-mediated attack on haematopoietic stem cells (HSCs). Stem cell transplantation and immunosuppressive therapy remain the major treatment choice for AA patients but have limited benefits and undesired side effects. The aim of our study was to clarify the protective role of immunity of chronic intermittent hypobaric hypoxia (CIHH) and the underlying mechanism in AA. Our integrative analysis demonstrated that CIHH pre-treatment significantly improved haematopoiesis and survival in an AA rat model. We further confirmed that CIHH pre-treatment was closely associated with the Th1/Th2 balance and a large number of negative regulatory haematopoietic factors, such as TNF-α and IFN-γ, produced by hyperactive Th1 lymphocytes released in AA rats, which induced the death program in a large number of CD34

Indexed as

Anemia, AplasticAnimalsAntigens, CD34Hematopoietic Stem CellsHumansHypoxiaRatsTumor Necrosis Factor-alphaAntigens, CD34Tumor Necrosis Factor-alphaAplastic anaemiaApoptosisChronic intermittent hypobaric hypoxiaHematopoietic stem cellsTh1/Th2 balance

Identifiers

PMID37831395
OpenAlexW4387597690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.